1. Home
  2. ICMB vs CELU Comparison

ICMB vs CELU Comparison

Compare ICMB & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

HOLD

Current Price

$3.05

Market Cap

38.8M

Sector

Finance

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.27

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICMB
CELU
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.8M
34.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ICMB
CELU
Price
$3.05
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
43.4K
31.7K
Earning Date
03-24-2026
11-14-2025
Dividend Yield
16.88%
N/A
EPS Growth
31.51
N/A
EPS
0.38
N/A
Revenue
$17,931,778.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.75
$76.00
P/E Ratio
$8.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.46
$1.00
52 Week High
$3.47
$4.35

Technical Indicators

Market Signals
Indicator
ICMB
CELU
Relative Strength Index (RSI) 63.48 44.78
Support Level $2.88 $1.20
Resistance Level $3.12 $1.31
Average True Range (ATR) 0.13 0.07
MACD 0.02 0.01
Stochastic Oscillator 88.89 41.75

Price Performance

Historical Comparison
ICMB
CELU

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: